Journal Club  by unknown
Kidney International (2012) 82             505
journal  c lubhttp://www.kidney-international.org
© 2012 International Society of Nephrology
Kidney International (2012) 82, 505–506. doi:10.1038/ki.2012.279
NF-kB inhibition delays DNA-
damage-induced senescence  
and aging in mice
Tilstra et al., J Clin Invest 2012; 122: 2601–2612; doi:10.1172/JCI45785
The ability to maintain homeostasis in response to stress 
declines with age, in part because of the accumulation of the 
effects of cellular injury, including DNA damage. Though it 
is well known that DNA damage can induce senescence and 
other hallmarks of cellular aging, the mechanisms by which 
DNA damage promotes aging are incompletely understood. 
Tilstra et al. studied an animal model of XFE progeroid syn-
drome, which is characterized by accelerated aging of virtually 
all organ systems, including the kidneys, due to the inability 
to repair endogenous DNA damage. The authors focused on 
the role of nuclear factor-kB (NF-kB), a transcription factor 
that is a central regulator of innate immunity, in the patho-
genesis of DNA-damage-induced inflammatory injury. Pro-
geroid mice had increased activation of NF-kB in the kidney, 
liver, pancreas, and muscle compared with wild-type mice. 
To determine whether NF-kB was necessary for the acceler-
ated aging phenotype, the investigators compared progeroid 
mice with heterozygous knockout of the NF-kB p65 subu-
nit and progeroid mice with wild-type p65. They found that 
p65 heterozygous mice had delayed onset of the progeroid 
phenotype as evidenced by improved appearance (Figure), 
delayed neurodegeneration and musculoskeletal deteriora-
tion, and reduced glomerulosclerosis and renal tubular cast 
formation. The investigators then studied whether inhibiting 
NF-kB activation by administration of a peptide inhibitor of 
IkB kinase (IKK) improved the aging phenotype in progeroid 
mice. The IKK inhibitor delayed onset of functional decline 
and histologic organ pathology similarly to heterozygous p65 
gene deletion. The investigators then used microarrays to 
determine the effect of the IKK inhibitor on gene expression 
in livers of progeroid mice. IKK inhibition reduced activation 
of typical NF-kB-regulated genes and normalized expression 
of genes involved in cell-cycle regulation, apoptosis, stress 
response, and DNA damage. Importantly, the authors then 
performed in vitro and in vivo studies that demonstrated that 
IKK inhibition prevented oxidative stress–induced senescence 
and protected progeroid mice from oxidative DNA damage.
This important article directly implicates NF-kB in the 
pathogenesis of aging, suggesting that NF-kB inhibition may 
be of benefit in the treatment of aging-related disorders.
Michael Ross
Syndecan–syntenin–ALIX regulates 
the biogenesis of exosomes
Baietti et al., Nat Cell Biol 2012; 14: 677–685; doi:10.1038/ncb2502
Exosomes are small secreted vesicles derived from the 
endosomal compartment, where budding of the endo-
somal membrane generates vesicle-containing endosomes 
(alternately referred to as late endosomes, multivesicular 
endosomes, or multivesicular bodies), which release vesicles 
outside the cell by fusion with the plasma membrane. The 
structure of exosomes comprises a lipid bilayer membrane, an 
array of membrane and cytosolic proteins, and selected RNA 
species. This molecular complexity suggests that exosomes 
may mediate a variety of physiological and pathological func-
tions. Indeed, a growing number of reports show that these 
vesicles are crucial in transferring information from one cell 
to another and play a crucial role in physiological as well as 
pathological activities. Exosomes are released by most cell 
types in the extracellular space; moreover, the presence of 
exosomes in vivo in many body fluids, including blood and 
urine, makes them readily accessible. In fact, human urine 
contains large numbers of exosomes, released from every 
renal epithelial cell type facing the urinary space. Thus, their 
study opens the possibility of obtaining information on the 
cell of origin in physiological and pathological conditions 
and of discovering molecular markers of renal dysfunction 
and structural injury. Despite the identification of a specific 
endosomal-sorting complex required for transport (ESCRT) 
machinery that regulates membrane budding, the intracellular 
processes that regulate exosomal cargo formation and the sub-
sequent abscission of vesicles are not completely understood. 
In this study, Baietti and collaborators performed a series 
of accurate biochemical and functional experiments using 
native and mutated proteins. They show that the connections 
between syndecans and syntenin and between syntenin and 
ALIX (apoptosis-linked gene 2-interacting protein X), a pro-
tein relevant to budding and abscission processes, support 
the biogenesis of exosomes and the segregation of signaling 
cargos to these specific vesicles. Through syndecan, heparan 
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sulphate is shown to play a crucial role in this process, as 
demonstrated by the reduction of exosome release when the 
heparan sulphate structure is disrupted. These data, therefore, 
add an additional role for heparan sulphate signaling, which 
is likely to prove relevant to several disease processes.
Maria Pia Rastaldi
Randomized phase 2b trial of 
tofacitinib (CP-690,550) in de 
novo kidney transplant patients: 
efficacy, renal function, and safety 
at 1 year
Vincenti et al., Am J Transplant advance online publication, 8 June 2012, 
doi:10.1111/j.1600-6143.2012.04127.x
The search for less nephrotoxic alternatives to calcineurin 
inhibitors in transplant patients continues. Janus kinase (JAK) 
is responsible for intracellular signal transduction of multi-
ple cytokines, including interleukin-2 (IL-2), IL-4, IL-7, IL-9, 
IL-15, and IL-21, which are essential for the function of T cells, 
B cells, and natural killer cells. Tofacitinib (CP-690,550) is an 
oral JAK inhibitor. In a phase 2b study, 331 low- to moderate-
risk de novo kidney transplant patients (approximately 60% 
deceased donors) were randomized to a more intensive (MI) or 
less intensive (LI) regimen of tofacitinib or cyclosporine (CsA). 
All patients received basiliximab induction, myco phenolic 
acid, and corticosteroids. The primary end points were inci-
dence of biopsy-proven acute rejection (BPAR) at month 6 
and measured glomerular filtration rate (GFR) at month 12. 
The incidence of BPAR was similar among the groups (11%, 
7%, and 9%, respectively), and measured GFRs were higher 
at month 12 in the MI and LI groups than in the CsA group 
(65, 65, and 54 ml/min, respectively). Fewer patients in the 
MI or the LI group developed chronic allograft nephropathy 
at month 12 compared with the CsA group (25%, 24%, and 
48%). However, serious infections developed in 45%, 37%, and 
25% of patients in the MI, LI, and CsA groups, respectively. 
Anemia, neutropenia, and post-transplant lympho proliferative 
disorder (PTLD) occurred more frequently in the MI and the 
LI groups than in the CsA group. 
In conclusion, tofacitinib was equivalent to CsA in prevent-
ing acute rejection and was associated with improved renal 
function and less chronic allograft nephropathy. The risk of 
serious infections and PTLD was much higher. This drug does 
have the potential to be used in a calcineurin inhibitor-free 
regimen; however, additional studies are needed to see 
whether the side effect profile can be improved.
Jai Radhakrishnan
Urinary neutrophil gelatinase-
associated lipocalin as biomarker 
in the differential diagnosis  
of impairment of kidney function 
in cirrhosis
Fagundes et al., J Hepatol 2012; 57: 267–273; doi:10.1016/j.
jhep.2012.03.015
Acute kidney injury (AKI) is not only more common in patients 
with advanced hepatic cirrhosis but is also associated with 
increased mortality. Currently, the most common causes of AKI 
are prerenal AKI (volume responsive), acute tubular necrosis 
(volume unresponsive), hepatorenal syndrome (HRS), and 
drug-induced nephrotoxicity. The cause of AKI has a prognostic 
impact on patient survival as well as an impact on the utilization 
and cost of health-care resources. Thus, there is a clinical need 
to develop a rapid diagnostic test that would help differentiate 
the cause of AKI, as serum creatinine is typically reduced in 
advanced cirrhosis because of lower creatine synthesis, protein 
energy wasting, and bilirubin interference with modified Jaffe 
colorimetric assays. Fagundes and colleagues measured uri-
nary neutrophil gelatinase associated lipocalin (uNGAL) in 241 
patients admitted with advanced cirrhosis. Patients with acute 
tubular necrosis had markedly higher uNGAL levels  (median 
417 (interquartile range 239–2242) mg/g creatinine) than those 
with prerenal AKI (30 (20–59) μg/g creatinine), underlying 
chronic kidney disease  82 (34–152) µg/g creatinine), and HRS 
(76 (43–263) µg/g creatinine). Among HRS patients, the highest 
values were found in HRS precipitated by infections, followed 
by classical (not associated with active infections) type 1 and 
type 2 HRS (391 (72–523), 147 (83–263), and 43 (31–74) mg/g 
creatinine, respectively). Patients with urinary tract infections 
had higher uNGAL (166 (82–412) mg/g creatinine) than those 
without urosepsis (42 (19–98) µg/g creatinine). In addition, 
there were statistically significant differences in uNGAL levels 
between classical type 1 HRS and acute tubular necrosis, chronic 
kidney disease, and prerenal AKI (volume responsive AKI).
Further multicenter studies are warranted to explore the sen-
sitivity and specificity of uNGAL in differentiating the causes of 
AKI in patients with advanced cirrhosis.
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